XML 34 R23.htm IDEA: XBRL DOCUMENT v3.25.1
SHARE-BASED COMPENSATION (Tables)
3 Months Ended
Mar. 31, 2025
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
SCHEDULE OF STOCK VALUATION ASSUMPTIONS

 

  

Three

Months
Ended
March 31,

2025

   

Three

Months
Ended
March 31,

2024

 
Risk-free interest rate   3.98 to 4.11%    1.80 
Expected dividend yield         
Expected term   5 years     5 years 
Expected volatility   50.92 to 52.84%    53.43 
SCHEDULE OF WARRANTS OUTSTANDING

For the three months ended March 31, 2025, warrant activity of the Company are as follows:

 

   Number of
shares
   Weighted
Average
Exercise
Price
   Weighted
average
remaining
contractual
life (in years)
   Aggregate
Intrinsic
Value
 
Outstanding at January 1, 2025   350,000   $1.06    7.07   $ 
Issued                
Exercised                
Expired/Forfeited                
Outstanding at March 31, 2025   350,000   $1.06    6.82   $ 

 

For the three months ended March 31, 2024, warrant activity of the Company are as follows:

 

   Number of
shares
   Weighted
Average
Exercise
Price
   Weighted
average
remaining
contractual
life (in years)
   Aggregate
Intrinsic
Value
 
Outstanding at January 1, 2024   350,000   $1.06    8.07   $ 
Issued                
Exercised                
Expired/Forfeited                
Outstanding at March 31, 2024   350,000   $1.06    7.82   $ 
                     
Vested and exercisable March 31, 2024                
Time Based Options [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
SCHEDULE OF STOCK OPTION ACTIVITY

For the three months ended March 31, 2025, stock option activity for time-based options of the Company is as follows:

 

   Number of
Time-Based
Share
Options
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Life (in
years)
   Aggregate
Intrinsic
Value
 
Outstanding at January 1, 2025   550,711   $1.36    7.87   $7,390 
Issued   608,500    1.56    9.87     
Exercised                
Expired/Forfeited       0.28    7.33     
Outstanding at March 31, 2025   1,159,211   $1.47    8.80   $16,643 
                     
Vested and exercisable March 31, 2025   349,753   $1.52    7.29   $12,643 
For the three months ended March 31, 2024, stock option activity for time-based options of the Company is as follows:

 

   Number of
Time-Based
Share
Options
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Life (in
years)
   Aggregate
Intrinsic
Value
 
Outstanding at January 1, 2024           366,615   $1.82    8.14   $15,686 
Issued   201,000    0.49    9.95     
Exercised                
Expired/Forfeited   (879)   0.28    7.33     
Outstanding at March 31, 2024   566,736   $1.35    5.10   $ 
                     
Vested and exercisable March 31, 2024   284,611   $1.78    7.86   $ 
 
Performance Based Options [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
SCHEDULE OF STOCK OPTION ACTIVITY

For the three months ended March 31, 2025, stock option activity for performance-based options of the Company is as follows:

 

   Number of
Performance-
Based Share
Options
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Life (in
years)
   Aggregate
Intrinsic
Value
 
Outstanding at January 1, 2025   894,500   $1.41    8.11   $ 
Issued                
Exercised                
Expired/Forfeited   (294,500)   (2.13)   (6.95)    
Outstanding at March 31, 2025   600,000   $1.06    6.82   $ 
                     
Vested and exercisable March 31, 2025                

 

For the three months ended March 31, 2024, stock option activity for performance-based options of the Company are as follows:

 

   Number of
Performance-
Based Share
Options
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Life (in
years)
   Aggregate
Intrinsic
Value
 
Outstanding at January 1, 2024   894,500   $1.41    8.11   $ 
Issued                
Exercised                
Expired/Forfeited                
Outstanding at March 31, 2024   894,500   $1.41    7.86   $ 
                     
Vested and exercisable March 31, 2024